ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 353,92
-0,60%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Bristol Myers Squibb Co (BMY)

  7. Bristol Myers Squibb Co (BMY) Actualités

BMY Bristol Myers Squibb Co

44,88
0,18 (0,40%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Bristol Myers Squibb Co BMY NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,18 0,40% 44,88 01:58:53
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
44,73 44,34 45,37 44,85 44,70
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
26/4/202412:59BWCHMP Adopts Positive Opinion Recommending Approval of..
25/4/202413:53IHMARKETNEWSU.S. Futures Drop in Pre-Market Trading as Tech Stocks..
25/4/202412:59BWBristol Myers Squibb Reports First Quarter Financial Results..
23/4/202413:25IHMARKETNEWSApple Loses Market Share in China, GM Surges in Pre-Market..
22/4/202412:59BWBristol Myers Squibb and Cellares Announce a $380M Worldwide..
08/4/202417:30BWKRAZATI (adagrasib) in Combination with Cetuximab..
06/4/202419:15BW Bristol Myers Squibb Presents New Pooled Interim Long-Term..
05/4/202415:05BWU.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s..
03/4/202402:08BWEuropean Commission Expands Approval of Bristol Myers..
02/4/202412:59BWBristol Myers Squibb Releases 2023 Environmental, Social and..
28/3/202421:05BWBristol Myers Squibb Announces Pivotal KRYSTAL-12..
28/3/202421:01BWBristol Myers Squibb Provides Update on the First Phase 3..
28/3/202412:30GLOBEPerspective Therapeutics Provides Recent Business Highlights..
26/3/202419:25BWA Bristol Myers Squibb Expande as Iniciativas de Doações..
26/3/202411:59BWBristol Myers Squibb Expands Health Equity Grant Initiatives..
25/3/202413:00BWBristol Myers Squibb to Present Data at the American College..
20/3/202421:45BWBristol Myers Squibb’s Abecma (idecabtagene vicleucel)..
20/3/202411:59BWBristol Myers Squibb Announces CheckMate -9DW Trial..
19/3/202411:59BWBristol Myers Squibb and Ted Danson Empower Those with..
18/3/202413:44BWBristol Myers Squibb Completes Acquisition of Karuna..
15/3/202423:27BWFDA Advisory Committee Votes in Favor of Bristol Myers..
15/3/202402:35BWU.S. FDA Approves Bristol Myers Squibb’s Breyanzi® as the..
11/3/202421:16BWBristol Myers Squibb to Report Results for First Quarter..
07/3/202420:23BWU.S. Food and Drug Administration Approves Opdivo®..
06/3/202422:17BWBristol Myers Squibb to Participate in Upcoming Investor..
04/3/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:52EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/3/202422:16BWBristol Myers Squibb Announces Dividend
29/2/202412:59BWBristol Myers Squibb Announces New Data from the Long-Term..
26/2/202422:16BWBristol Myers Squibb to Participate in the TD Cowen 44th..
26/2/202414:35BWBristol Myers Squibb Completes Acquisition of RayzeBio,..
24/2/202400:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/2/202413:34EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
23/2/202412:59BWBristol Myers Squibb Announces Expiration of RayzeBio Tender..
22/2/202422:15EDGAR2Form 8-K - Current report
20/2/202412:59BWU.S. Food and Drug Administration (FDA) Accepts Supplemental..
15/2/202401:57BWBristol Myers Squibb Prices $13 Billion of Senior Unsecured..
14/2/202422:16BWBristol Myers Squibb Recommends Stockholders Reject..
14/2/202412:59BWU.S. Food and Drug Administration Accepts for Priority..
12/2/202412:59BWBristol Myers Squibb and RayzeBio Announce Expiration of HSR..
07/2/202412:59BWBristol Myers Squibb Announces Acceptance of U.S. and EU..
05/2/202415:00BWBristol Myers Squibb Named One of America’s Most JUST..
05/2/202412:59BWBristol Myers Squibb and 2seventy bio Share Update on U.S...
02/2/202412:59BWBristol Myers Squibb Reports Fourth Quarter and Full-Year..
30/1/202412:59BWRegulatory Applications Accepted in the U.S. and Japan for..
27/1/202416:00BWSubcutaneous Nivolumab (nivolumab and hyaluronidase) Shows..
26/1/202413:13BWBristol Myers Squibb Receives Positive CHMP Opinion for CAR..
25/1/202414:13EDGAR2Form SC TO-T - Tender offer statement by Third Party
23/1/202414:30BWBristol Myers Squibb Completes Acquisition of Mirati..
22/1/202423:05BWEight-Year Data for Opdivo (nivolumab) Plus Yervoy..

Dernières Valeurs Consultées

NYSE
BMY
Bristol Myers Squibb
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés